Judge conditionally approves Purdue Pharma opioid settlement, shielding Sackler family from future lawsuits
CBSN
A federal bankruptcy judge on Wednesday gave conditional approval to a sweeping, potentially $10 billion plan submitted by OxyContin maker Purdue Pharma to settle a mountain of lawsuits over its role in the opioid crisis that has killed a half-million Americans over the past two decades.
Under the settlement reached with creditors including individual victims and thousands of state and local governments, the Sackler family will give up ownership of the company and contribute $4.5 billion but will be freed from any future lawsuits over opioids. The drugmaker will be reorganized into a new company with a board appointed by public officials and will funnel its profits into government-led efforts to prevent and treat opioid addiction.Two Native Hawaiian brothers who were convicted in the 1991 killing of a woman visiting Hawaii allege in a federal lawsuit that local police framed them "under immense pressure to solve the high-profile murder" then botched an investigation last year that would have revealed the real killer using advancements in DNA technology.
In one of his first acts after returning to the Oval Office this week, President Trump tasked federal agencies with developing ways to potentially ease prices for U.S. consumers. But experts warn that his administration's crackdown on immigration could both drive up inflation as well as hurt a range of businesses by shrinking the nation's workforce.